Metabiomics
  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
Select Page
FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer

FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer

by Greg Kuehn | Sep 5, 2019 | Press Releases

CARLSBAD, Calif., Sept. 4, 2019 /PRNewswire/ — Prescient Metabiomics, a privately held company and a subsidiary of Prescient Medicine Holdings, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted the company’s submission...

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening March 20, 2020
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test December 17, 2019
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer September 5, 2019

Tag Cloud

Breakthrough Device China clinical studies colon cancer screening colon cancer test colon polyp Colorado Capital Conference colorectal adenoma colorectal cancer colorectal cancer diagnostics colorectal cancer screening CoreBiome Curtis Huttenhower Dan Knights Harvard Investor conference Keri Donaldson Kindstar LifeKit Prevent MB-01 MBAC Metabiomics Metagenomics Microbiome microbiome diagnostics microbiome sampling kit Mid-Atlantic Bio molecular diagnostics MultiTag Sequencing neoplasia Next-Generation Sequencing OCTANe Medical Device & Investor Forum Oricol Origin Sciences patents Patrick Gillevet Prescient Medicine Series A

RSS Feeds

  • RSS - Posts
  • RSS - Comments

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer

Navigation

  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
  • Facebook
  • X
  • RSS

Designed by Elegant Themes | Powered by WordPress